Your email has been successfully added to our mailing list.

×
0 0 0 0 -0.0740740740740741 -0.0740740740740741 -0.12962962962963 -0.145188888888889
Stock impact report

Cancer Genetics up 16% on collaborating with Cellaria for precision medicine tools [Seeking Alpha]

CANCER GENETICS (CGIX) 
Last cancer genetics earnings: 11/19 04:16 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.cancergenetics.com
Company Research Source: Seeking Alpha
Cancer Genetics (NASDAQ: CGIX ) collaborates with Cellaria, LLC to develop extensive precision medicine tools and platform technologies to support the development of new cancer therapeutics. This collaboration came about as part of Cancer Genetic's 2018 transformation strategy. Financial terms are not disclosed. CGIX shares are up   premarket See all stocks on the move » Now read: Expected Value Investing:  The Case Against Galmed » Subscribe for full text news in your inbox Show less Read more
Impact Snapshot
Event Time:
CGIX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for CGIX alerts
Opt-in for
CGIX alerts

from News Quantified
Opt-in for
CGIX alerts

from News Quantified